MedDataX Logo

Group B Streptococcus Infection and PROM Incidince

NCT ID: NCT06735703

Last Updated: 2024-12-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-12-25

Study Completion Date

2026-01-09

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To investigate incidince of prom with GBS infection and role of prophylaxis against it

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Premature Rupture of Fetal Membranes Group B Streptococcal Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pregnant women after 34 wks with PROM

To provide ampicillin sulbactam to pregnant women with premature rupture of membrane

Intervention Type DRUG

To provide ampicillin sulbactam tonpregnant women with premature rupture of membrane after 34 wks gestation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

To provide ampicillin sulbactam to pregnant women with premature rupture of membrane

To provide ampicillin sulbactam tonpregnant women with premature rupture of membrane after 34 wks gestation

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pregnant women with prom after 34 wks festation

Exclusion Criteria

* Bleeding disorder
* emergency conditions
Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assiut University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dina Mohamed Kamel

Dina mohamedkamel

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Dina Mohamed Kamel

Role: CONTACT

Phone: 0927923623

Email: [email protected]

Sherif Abdelmeged badran

Role: CONTACT

Phone: 0927923623

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GBS WITH PROM

Identifier Type: -

Identifier Source: org_study_id